-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CeIgFT/P2Y7LGsIWBsuqhu3oQ4u6sqo5Fn33bwZL6UnDzMgMx1txRB8rI7Wqf7wk D1lzHt7IqTppXCfriW9wjw== 0000950144-06-008054.txt : 20060817 0000950144-06-008054.hdr.sgml : 20060817 20060817160857 ACCESSION NUMBER: 0000950144-06-008054 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060816 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20060817 DATE AS OF CHANGE: 20060817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDCATH CORP CENTRAL INDEX KEY: 0001139463 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 562248952 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33009 FILM NUMBER: 061040988 BUSINESS ADDRESS: STREET 1: 10720 SIKES PLACE SUITE 300 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 7047086600 MAIL ADDRESS: STREET 1: 10720 SIKES PLACE SUITE 300 CITY: CHARLOTTE STATE: NC ZIP: 28277 8-K 1 g03021k2e8vk.htm MEDCATH CORPORATION MedCath Corporation
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Date of Report (Date of earliest event reported): August 16, 2006
MEDCATH CORPORATION
(Exact name of registrant as specified in its charter)
         
Delaware   000-33009   56-2248952
(State or other jurisdiction of   (Commission File Number)   (IRS Employer Identification No.)
incorporation or organization)        
10720 Sikes Place
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)
(704) 708-6600
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13d-4(c))
 

 

 

Item 1.01. Entry into a Material Definitive Agreement.
     On August 16, 2006, MedCath Corporation (MedCath or the Company) entered into an agreement with John T. Casey, Chairman of the Board, providing for Mr. Casey’s resignation as an employee of the Company effective August 21, 2006. Mr. Casey retired as the Company’s Chief Executive Officer on February 21, 2006, and agreed to continue to serve as an employed Chairman for a transition period. He will continue to serve as a non-employee director and Chairman of the Board following the effective date of his resignation as an employee, and will receive standard non-employee director fees and stock option grants for Board service and an additional fee of $25,000 per year for serving as Chairman.
     Under the agreement, Mr. Casey agreed to forfeit options to purchase 432,000 shares of common stock due to resale restrictions that would have applied to shares acquired upon exercise of those options under the Company’s stock option plan. His remaining options to purchase 288,000 shares of common stock will expire on the first business day which is 90 calendar days after August 21, 2006. Mr. Casey has informed the Company that he intends to exercise these options prior to such expiration.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
 
  MEDCATH CORPORATION
 
        
Date: August 17, 2006
  By:   /s/James E. Harris
 
       
 
      James E. Harris
Executive Vice President and Chief Financial Officer
Page 2

-----END PRIVACY-ENHANCED MESSAGE-----